FAEGRE DRINKER BIDDLE & REATH LLP

Lobbying for FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS · Patient advocacy.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $30,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Health Issues

Medical research, FDA regulatory, Public health, Medicaid

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem